United Therapeutics | UTHR - Stock


United Therapeutics reported $183.1M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Amarin USD 184.7M 13.46M Sep/2025
Ardelyx USD 129.36M 107.08M Sep/2025
Baxter International USD 2.23B 228M Dec/2025
Bayer EUR 12.33B 221M Sep/2025
BioCryst Pharmaceuticals USD 5.4M 166K Dec/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Halozyme Therapeutics USD 176.48M 9.32M Dec/2025
Insmed USD 132.07M 11.1M Dec/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
J&J USD 14.19B 45M Dec/2025
Lexicon Pharmaceuticals USD 168K 33K Jun/2025
Moderna USD 332M 92M Sep/2025
Omeros USD 712K 266K Sep/2021
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
United Therapeutics USD 183.1M 6.6M Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025